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LITTLE information as yet is obtainable on the reliability of the pre-treatment
glucose tolerance test as an indication of subsequent control of diabetes on
chlorpropamide. Agreement on other indications of likely success (age of onset
of diabetes over 40 years, absence of previous ketosis, relative stability, etc.) has
been reached in numerous papers (Murray, et al. (1958), Hills and Abelove
(1959), Lowenthal, et al. (1959), Ruiz-Gui'a (1959), De Salcedo and Borges (1959),
Reyes, et al. (1959), Duncan, et al. (1959), Hamwi, et al. (1959), and others).
It must be admitted, however, that even in diabetes arising before the age of 40
and not apparently brittle there may be a good response to chlorpropamide.
Yuen (1959) claims good results in young diabetics and Jackson and Oakley
(1959) have been encouraged by the outcome of chlorpropamide treatment in
a few diabetic adolescents and children diagnosed prior to the development of
symptoms and ketosis. There would not appear, therefore, to be any absolute
criterion of future control.
The present study was undertaken to investigate the initial glucose tolerance
test in a series of diabetic patients treated with chlorpropamide and to compare
this curve with the subsequent outcome after three months of treatment. A small
group of brittle diabetics was similarly analysed for comparison.
MATERIAL AND METHODS.
A total of sixty patients were selected for study comprising forty-eight stable
diabetics who had been treated on chlorpropamide and whose pre-treatment
glucose tolerance curves were available. In addition the initial glucose tolerance
tests of twelve patients with ketosis (brittle diaibetics) subsequently treated on
insulin were used for comparison. Clinical details of some of these patients have
previously been reported (Grant and Boyd, 1959). In all instances true blood
glucose estimations were performed on venous blood by a modification of the
anthrone method of Handelsman and Sass (1956).
Glucose tolerance curves.
Glucose tolerance tests were undertaken with the patients on average normal
diet prior to testing. Using 50 gms. dextrose in 6 ozs. of warm water orally after
fasting overnight and at rest in bed, a routine glucose tolerance test was performed
38with an initial fasting and four half-hourly post-prandial blood samples for
estimation of blood sugar level (B.S.L.).
The curves were analysed for profile and the initial (fasting) level, the peak
value and the steepness of the curve in each patient observed as indicating the
severity of the diabetic state. The profile was assessed by means of a simple sign
test, all blood sugar values differing by less than 11 mg./100 ml. being considered
within the error of the technique. A plus was given for a rise above the previous
level, a minus for a fall, and a zero for no change (Fig. 1).
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Fig. 1-Analysis of profiles of the pre-treatment glucose tolerance tests
of sixty diabetic patients with sign test. (For explanation see text.)
Response to chlorpropamide.
On completion of three months' chlorpropamide treatment the forty-eight
patients were assessed and placed in suitable response categories (Table I).
Patients showing ketosis or obviously out of control were not, of course,
continued on chlorpropamide but classified forthwith.
The criteria used were modified from those of Cardonnet, et al. (1959), and
Sugar, et al. (1959), as giving a reasonably good idea of control with the
information available. The groups were defined as follows:-
Excellent - -
Good
Fair
Poor
Non-ketotic failure -
Ketotic failure
FASTING BSL. AVERAGE DAILY B.S.L.
mg./100 ml. mg./100 ml.
under 120 ... under 200
under 150 ... under 200
under 180 ... under 200
over 180 ... under 220
... over 220
. . . over 220+ketonuria.
39TABLE I.
COMPARISON OF INITIAL GLUCOSE TOLERANCE TEST PROFILES AND MEAN INITIAL
AND PEAK BLOOD SUGAR LEVELS WITH RESPONSE CATEGORY IN FORTY-EIGHT
STABLE DIABETIC PATIENTS TREATED ON CHLORPROPAMIDE AND WITH GLUCOSE
1lOLERANCE RESULTS IN TWELVE BRI'rrLE DIABETIC PATIENTS SUBSEQUENTLY
TREATED ON INSULIN.
INITIAL LEVEL PEAK LEVEL PROFILE Mg./loG Ml. Mg./1oo Ml.
TYPE OF DIABETES Z
AND TREATMENT
CC
04 ~~~~~~~~~~~~~~0
With Chlorpropamide
(Non-brittle):
Excellent - - 24...5...6...4...225... 400- 560-
Good - - - 123 ... 226 ...
Fair - - - 2...1...2 ...-... 228
... ... 329 ...37
... 5
133 264
Poor - - - 288- 392-
Failure - - 2 220 174 ...365 ... 4
Without Chopoaie276 564 WitoutChlorpropamide 8... 3 ... ... - ... 214 142 25445
8 *56 12
(Brittle) 14-..28-.
RESULTS.
Initial glucose tolerance test curves.
The analysis of results obtained in the sixty patients is shown in Table I, where
"excellent" and "good" responses are combined as are "poor" results and "non-
ketotic failures" to form with "fair" response patients, three categories. The
results in non-brittle and brittle patients are shown separately.
Glucose tolerance test profile.
The patterns of shape encountered in the curves of the series are shown in
Fig. 1, where they have been somewhat arbitrarily divided into four groups.
"Early fall" was classified if the only feature was a consistent fall at E or 1 hour.
"Delayed rise" was considered descriptive of all curves not showing a rise in
B.S.L. until one hour while "irregular" patterns showed prominent fluctuations
in the B.S.L. All other responses were placed in the "regular" group. Although
initially the four response categories-excellent and good, fair, poor and brittle
were tabulated under the individual patterns encountered as shown in Fig. 1,
40it was obvious that the scatter was too great and irregular for any trend to be
seen and in Table I the analysis shows only the number of each category classified
in the four profile groups defined above. Most patients can be seen to show the
"regular" type of glucose tolerance curve with a steadily rising B.S.L. from the
initial value and without a fall before 1j hours. This was the principal pattern
present in both brittle and non-brittle diabetics.
The only suggestion presented from this analysis is that "irregular" profiles are
proportionately more common in the poor response categories of chlorpropamide
treated diaDetics, and that brittle patients tend towards more regular profiles.
Anialysis of the glucose tolerance test profile, however, proved disappointing and
showed no clear distinction between the curves of either brittle or non-brittle
diabetic patients nor could the type of curve be related to the subsequent response
to chlorpropamide treatment.
Initial and peak levels of glucose tolerance tests.
The means of the initial and peak values for the glucose tolerance test blood
suigar levels with-their ranges are categorised also under the response groups in
Table I. No significant difference could be found between the initial (fasting)
levels in the diabetic response groups, any variation being between individual
patients and unrelated to the chlorpropamide response or the presence of ketosis.
The patient with the highest initial level of the series at 400 mg./100 ml.
responded excellently to chlorpropamide while that with one of the lowest
(142 mg./100 ml.) showed ketonuria. High initial values were associated with
high peak B.S.Ls. The two highest peak B.S.Ls. were 560 and 564 mg./100 ml.
These two patients fell into the excellent response category and brittle diabetic
group respectively. Again the analysis of glucose tolerance test initial and peak
blood sugar levels proved unhelpful in forecasting response to chlorpropamide.
DiscusSION.
Comparison of the initial and treatment glucose tolerance tests of diabetic
patients treated on chlorpropamide has been undertaken by a number of workers.
Investigations have shown that the mean glucose tolerance curve is depressed in
a manner parallel to the mean pre-treatment contour; the suggestion being that
chlorpropamide causes a general improvement in glucose tolerance while not
altering the utilisation of glucose as shown by the mean profile of glucose
tolerance tests (De Salcedo and Borges (1959), Lundback, et al. (1959), Dobson,
et al. (1959), Grant and Boyd (1959). Reyes, et al. (1959), describe flattening
and depression of the curve in ten patients after six days' chlorpropamide treat-
ment, while Stowers, et al. (1959), suggest that the fasting blood glucose is
reduced to a greater extent than the post-prandial levels on chlorpropamide. A
possible relationship between the initial glucose tolerance test and the patient's
response to treatment is not considered in the above papers.
Little information is available regarding the reliability of the oral glucose
tolerance test as an indication of the severity of diabetes. In the interpretation
of the test Joslin, et al. (1959), stress the importance of such factors as the
previous physical and nutritional state, the patient's age, absence of infection,
41
Nstate of mobility, absence of associated thyroid or pituitary overactivity and the
ensurence of a normal balance of dietary protein, carbohydrate and fat. Assuming
also that there is no defect of absorption, the initial hyperglycaemia and the shape
of the post-ingestion glucose tolerance curve in the diabetic patient are due to
lack of insulin and the consequent failure of the body to respond to the increase
in body fluid glucose. The final fall of the blood sugar is due mainly to the
excretion of glucose in the urine (Wright, 1957).
Blotner (1947) states that interpretation of the oral glucose tolerance test by
the peak blood sugar level and rate of fall is probably the safest method in
diagnosis. He considers the curve to be consistent enough to be of great value
in the diagnosis of diabetes and groups patients into degrees of severity on the
TABLE II.
DUPLICATE GLUCOSE TOLERANCE 1TEST RESULTS IN THREE STABLE DIABETICS
GIVING AN EXCELLENT RESPONSE TO CHLORPROPAMIDE AND IN ONE BRITTLE
DIABETIC PATIENT.
B.S.L. in Mg./100 Ml.
GLUCOSE TOLERANCE TESTS
AND o
RESPONSE GROUPS 0 0 0
(Nov., 1955 - 268 ... 298 ... 302 ... 274 ... 274
ExCELLENT - -Sept., 1959 - 174 ... 191 ... 242 ... 322 ... 340
RESPONSE - July, 1951 - 194 ... 250 ... 292 ... 242 ... 248
GROUP - Aug., 1951 - 121 ... 137 ... 210 ... 262 ... 260
IJuly, 1958 - 187 ... 228 ... 294 ... 348 ... 314
,May, 1959 - 132 ... 141 ... 237 ... 218 ... 268
BRITTLE - - {Dec., 1957 - 151 ... 156 ... 188 ... 223 ... 164
Jan., 1958 - 190 ... 218 ... 230 ... 246 ... 258
contour of the glucose tolerance test as does Lawrence (1947). Except in patients
with malabsorption neither Blotner (1947) nor Lawrence (1947) found any
advantage in the various forms of intravenous test. Increased precision in the
glucose tolerance test by the exclusion of non-glucose reducing substances
(estimated in the Folin-Wu method) is stressed by Mosenthal (1947), while
Beckwith (1947) is concerned mainly with the rate of fall in the blood sugar at
two hours in the interpretation of the glucose tolerance curve. In spite of the
many influencing factors, Bodansky and Bodansky (1947) consider the response
in the diabetic patient to be usually quite distinctive though with considerable
variation, depending in large measure on the severity of the diabetes. Varley
(1958), while also commenting on possible fallacies, considers the glucose tolerance
42curve of considerable use in investigating abnormnalities of carbohydrate
metabolism. Indeed there is as yet no better means of diagnosis and of assessing
the severity of diabetes.
From the above information it was felt, therefore, that the pre-treatment
glucose tolerance test profile and initial and peak blood sugar level results might
correlate with the outcome of chlorpropamide treatment and be useful in predict-
ing results. Unfortunately, no relationship could be demonstrated on the most
careful comparison. The reason for this lies in the unreliability of the test even
when repeated in the same individual. Most discrepancies in the repeated glucose
tolerance test have been noted in investigations in non-diabetic patients. Freeman,
et al. (1942), wlhile remarking on the sparcity of information on the reliability
of the oral glucose tolerance test in normal subjects, found average variation in
the fasting blood sugar of 9 (range 0-30) mg./100 ml., 31 (range 0-90) mg./100 ml.
at 1 hour and 20 (range 0-50) mg./100 ml. at 2 hours on repeating the standard
oral glucose tolerance test on 35 non-diabetic patients after an average interval
of four to seven weeks. In the diabetic patient Bodansky and Bodansky (1947)
and Stewart and Dunlop (1949) refer to divergence in the results of glucose
tolerance tests repeated on the same individual after short time intervals, and
Anderson, et al. (1956), in 100 unselected persons, found mean variations in the
post-absorptive blood sugar of 22.2 mg./100 ml. when specimens were taken at
two-minute intervals. Examples of the variation in glucose tolerance test results
in four of our own patients are shown in Table II-results discovered in
retrospect.
SUMMARY AND CONCLUSIONS.
A series of 48 stable and 12 brittle diabetic patients was analysed regarding the
profile and the initial and peak blood sugar levels of the standard oral glucose
tolerance test and the outcome of chlorpropamide treatment. No relationship
could be discovered nor was there any distinguishing feature between the glucose
tolerance test result of stable or brittle diabetics.
The literature related to the glucose tolerance test in patients treated on
chlorpropamide is reviewed and reference is made to the unreliability of the test
as a means of assessing severity of diabetes.
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